HEADER RECEPTOR 20-JAN-09 2W8Y TITLE RU486 BOUND TO THE PROGESTERONE RECEPTOR IN A DESTABILIZED AGONISTIC TITLE 2 CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PR LBD, RESIDUES 678-933; COMPND 5 SYNONYM: PR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RECEPTOR, PROGESTERONE RECEPTOR, RU-486, MIFEPRISTONE EXPDTA X-RAY DIFFRACTION AUTHOR H.C.A.RAAIJMAKERS,J.VERSTEEG,J.C.M.UITDEHAAG REVDAT 4 27-DEC-17 2W8Y 1 AUTHOR REMARK REVDAT 3 13-JUL-11 2W8Y 1 VERSN REVDAT 2 21-JUL-09 2W8Y 1 JRNL REVDAT 1 28-APR-09 2W8Y 0 JRNL AUTH H.C.A.RAAIJMAKERS,J.VERSTEEGH,J.C.M.UITDEHAAG JRNL TITL THE X-RAY STRUCTURE OF RU486 BOUND TO THE PROGESTERONE JRNL TITL 2 RECEPTOR IN A DESTABILIZED AGONISTIC CONFORMATION. JRNL REF J.BIOL.CHEM. V. 284 19572 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19372222 JRNL DOI 10.1074/JBC.M109.007872 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0078 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 43248 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2333 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2393 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.54 REMARK 3 BIN R VALUE (WORKING SET) : 0.3590 REMARK 3 BIN FREE R VALUE SET COUNT : 130 REMARK 3 BIN FREE R VALUE : 0.4180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4046 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 200 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 21.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.11000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.12000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.142 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.128 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.098 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.412 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4265 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2934 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5790 ; 1.082 ; 2.003 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7210 ; 0.844 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 515 ; 4.817 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;34.596 ;24.407 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 803 ;13.045 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;10.728 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 664 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4568 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 820 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2540 ; 1.064 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4134 ; 1.747 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1725 ; 1.230 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1650 ; 1.926 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 683 A 933 REMARK 3 ORIGIN FOR THE GROUP (A): 17.4010 -0.0170 2.0110 REMARK 3 T TENSOR REMARK 3 T11: 0.1048 T22: 0.1354 REMARK 3 T33: 0.0350 T12: -0.0091 REMARK 3 T13: 0.0248 T23: 0.0030 REMARK 3 L TENSOR REMARK 3 L11: 0.9737 L22: 1.8174 REMARK 3 L33: 1.5617 L12: 0.2356 REMARK 3 L13: -0.3644 L23: 0.6069 REMARK 3 S TENSOR REMARK 3 S11: 0.0312 S12: -0.0706 S13: 0.0742 REMARK 3 S21: 0.0926 S22: 0.0147 S23: 0.0503 REMARK 3 S31: -0.0126 S32: 0.1387 S33: -0.0459 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 683 B 933 REMARK 3 ORIGIN FOR THE GROUP (A): -4.0660 12.3560 -33.0040 REMARK 3 T TENSOR REMARK 3 T11: 0.1501 T22: 0.0651 REMARK 3 T33: 0.0206 T12: 0.0063 REMARK 3 T13: 0.0537 T23: 0.0112 REMARK 3 L TENSOR REMARK 3 L11: 1.2838 L22: 2.0964 REMARK 3 L33: 1.4236 L12: -0.3148 REMARK 3 L13: 0.1800 L23: -0.3394 REMARK 3 S TENSOR REMARK 3 S11: -0.0543 S12: -0.0672 S13: -0.0615 REMARK 3 S21: 0.1313 S22: 0.0174 S23: -0.0349 REMARK 3 S31: 0.0746 S32: -0.0264 S33: 0.0370 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES RESIDUAL ONLY. THE DIMETHYLAMINOREMARK A909. REMARK 3 IN REALITY WE PROBABLY OBSERVE THE AVERAGE OF AN ENSEMBLE OF REMARK 3 SUBTLY DIFFERENT DIMETHYLANILINE AND MET909 ORIENTATIONS, EACH REMARK 3 STERICALLY ALLOWED. FOR THE FINAL REFINEMENT I SET THE OCCUPANCY REMARK 3 OF M909 SIDECHAIN TO 0, TO IMPROVE THE FIT OF THE REMARK 3 DIMETHYLANILINE TO THE ELECTRON DENSITY. REMARK 4 REMARK 4 2W8Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1290038546. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9340 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45609 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.90000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG4000, 0.1M HEPES 6.5, 100 MM REMARK 280 LI2SO4, PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.94850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 674 REMARK 465 SER A 675 REMARK 465 HIS A 676 REMARK 465 MET A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 GLN A 682 REMARK 465 GLY B 674 REMARK 465 SER B 675 REMARK 465 HIS B 676 REMARK 465 MET B 677 REMARK 465 GLY B 678 REMARK 465 GLN B 679 REMARK 465 ASP B 680 REMARK 465 ILE B 681 REMARK 465 GLN B 682 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 932 CG CD CE NZ REMARK 470 LYS A 933 CA C O CB CG CD CE REMARK 470 LYS A 933 NZ REMARK 470 LYS B 932 CG CD CE NZ REMARK 470 LYS B 933 CA C O CB CG CD CE REMARK 470 LYS B 933 NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MET A 909 CB CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 793 -15.77 99.98 REMARK 500 PHE A 794 52.42 -142.55 REMARK 500 SER A 837 51.44 -102.11 REMARK 500 GLN A 916 -16.23 -150.00 REMARK 500 MET A 924 42.10 -93.77 REMARK 500 LYS A 932 -85.75 -77.47 REMARK 500 LEU B 782 78.37 -150.91 REMARK 500 MET B 789 68.78 -108.41 REMARK 500 SER B 837 49.98 -102.17 REMARK 500 GLN B 916 -15.78 -140.93 REMARK 500 MET B 924 41.96 -91.83 REMARK 500 LYS B 932 -165.57 -68.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 NORETHINDRONE (NDR): ALSO KNOWN AS NORETHISTERONE REMARK 600 MIFEPRISTONE (486): RU486, 11BETA-4-N, REMARK 600 N-DIMETHYLAMINOPHENYL-17ALPHA-PROP-1-YNYL-DELTA4, REMARK 600 9-ESTRADIENE-17BETA-OL-3-ONE REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 486 A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDR B 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1934 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1934 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C7A RELATED DB: PDB REMARK 900 STRUCTURE OF THE PROGESTERONE RECEPTOR-DNA COMPLEX REMARK 900 RELATED ID: 1A28 RELATED DB: PDB REMARK 900 HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAIN REMARK 900 RELATED ID: 1ZUC RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITHTHE REMARK 900 NONSTEROIDAL AGONIST TANAPROGET REMARK 900 RELATED ID: 1SQN RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN WITH BOUNDNORETHINDRONE REMARK 900 RELATED ID: 1SR7 RELATED DB: PDB REMARK 900 PROGESTERONE RECEPTOR HORMONE BINDING DOMAIN WITH BOUNDMOMETASONE REMARK 900 FUROATE REMARK 900 RELATED ID: 1E3K RELATED DB: PDB REMARK 900 HUMAN PROGESTERON RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH REMARK 900 THE LIGAND METRIBOLONE (R1881) DBREF 2W8Y A 674 677 PDB 2W8Y 2W8Y 674 677 DBREF 2W8Y A 678 933 UNP P06401 PRGR_HUMAN 678 933 DBREF 2W8Y B 674 677 PDB 2W8Y 2W8Y 674 677 DBREF 2W8Y B 678 933 UNP P06401 PRGR_HUMAN 678 933 SEQRES 1 A 260 GLY SER HIS MET GLY GLN ASP ILE GLN LEU ILE PRO PRO SEQRES 2 A 260 LEU ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE SEQRES 3 A 260 TYR ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SEQRES 4 A 260 SER LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN SEQRES 5 A 260 LEU LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY SEQRES 6 A 260 PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE SEQRES 7 A 260 GLN TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY SEQRES 8 A 260 TRP ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR SEQRES 9 A 260 PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS SEQRES 10 A 260 GLU SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN SEQRES 11 A 260 ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU SEQRES 12 A 260 GLU PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR SEQRES 13 A 260 ILE PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU SEQRES 14 A 260 GLU MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA SEQRES 15 A 260 ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN SEQRES 16 A 260 ARG PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS SEQRES 17 A 260 ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR SEQRES 18 A 260 PHE ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU SEQRES 19 A 260 MET MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE SEQRES 20 A 260 LEU ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS SEQRES 1 B 260 GLY SER HIS MET GLY GLN ASP ILE GLN LEU ILE PRO PRO SEQRES 2 B 260 LEU ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE SEQRES 3 B 260 TYR ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SEQRES 4 B 260 SER LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN SEQRES 5 B 260 LEU LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY SEQRES 6 B 260 PHE ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE SEQRES 7 B 260 GLN TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY SEQRES 8 B 260 TRP ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR SEQRES 9 B 260 PHE ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS SEQRES 10 B 260 GLU SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN SEQRES 11 B 260 ILE PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU SEQRES 12 B 260 GLU PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR SEQRES 13 B 260 ILE PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU SEQRES 14 B 260 GLU MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA SEQRES 15 B 260 ILE GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN SEQRES 16 B 260 ARG PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS SEQRES 17 B 260 ASP LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR SEQRES 18 B 260 PHE ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU SEQRES 19 B 260 MET MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE SEQRES 20 B 260 LEU ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS HET 486 A1000 32 HET SO4 A1934 5 HET NDR B1000 22 HET EDO B1934 4 HETNAM 486 11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17- HETNAM 2 486 PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC HETNAM 3 486 AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE HETNAM SO4 SULFATE ION HETNAM NDR (14BETA,17ALPHA)-17-ETHYNYL-17-HYDROXYESTR-4-EN-3-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN 486 RU-486, MIFEPRISTONE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 486 C29 H35 N O2 FORMUL 4 SO4 O4 S 2- FORMUL 5 NDR C20 H26 O2 FORMUL 6 EDO C2 H6 O2 FORMUL 7 HOH *200(H2 O) HELIX 1 1 PRO A 685 ILE A 694 1 10 HELIX 2 2 THR A 710 LEU A 736 1 27 HELIX 3 3 GLY A 738 LEU A 742 5 5 HELIX 4 4 HIS A 743 SER A 772 1 30 HELIX 5 5 ASN A 785 GLU A 791 1 7 HELIX 6 6 PHE A 794 GLN A 812 1 19 HELIX 7 7 SER A 814 LEU A 827 1 14 HELIX 8 8 SER A 837 LEU A 858 1 22 HELIX 9 9 GLY A 862 GLN A 897 1 36 HELIX 10 10 GLN A 897 SER A 902 1 6 HELIX 11 11 PRO A 906 ALA A 922 1 17 HELIX 12 12 PRO B 685 ILE B 694 1 10 HELIX 13 13 THR B 710 LEU B 736 1 27 HELIX 14 14 GLY B 738 LEU B 742 5 5 HELIX 15 15 HIS B 743 SER B 772 1 30 HELIX 16 16 ASN B 785 MET B 789 5 5 HELIX 17 17 GLU B 791 GLN B 812 1 22 HELIX 18 18 SER B 814 LEU B 827 1 14 HELIX 19 19 SER B 837 LEU B 858 1 22 HELIX 20 20 GLY B 862 GLN B 897 1 36 HELIX 21 21 GLN B 897 SER B 902 1 6 HELIX 22 22 PRO B 906 ALA B 922 1 17 SHEET 1 AA 2 LEU A 776 ALA A 779 0 SHEET 2 AA 2 LEU A 782 LEU A 784 -1 O LEU A 782 N ALA A 779 SHEET 1 AB 2 THR A 829 ILE A 830 0 SHEET 2 AB 2 LYS A 926 PRO A 927 -1 O LYS A 926 N ILE A 830 SHEET 1 BA 2 LEU B 776 ALA B 779 0 SHEET 2 BA 2 LEU B 782 LEU B 784 -1 O LEU B 782 N ALA B 779 SHEET 1 BB 2 THR B 829 PRO B 831 0 SHEET 2 BB 2 VAL B 925 PRO B 927 -1 O LYS B 926 N ILE B 830 SITE 1 AC1 18 LEU A 715 LEU A 718 ASN A 719 LEU A 721 SITE 2 AC1 18 GLY A 722 GLU A 723 GLN A 725 TRP A 755 SITE 3 AC1 18 MET A 756 MET A 759 ARG A 766 PHE A 794 SITE 4 AC1 18 LEU A 797 MET A 801 TYR A 890 CYS A 891 SITE 5 AC1 18 MET A 909 HOH A2016 SITE 1 AC2 10 LEU B 715 LEU B 718 ASN B 719 GLN B 725 SITE 2 AC2 10 MET B 756 MET B 759 ARG B 766 MET B 801 SITE 3 AC2 10 TYR B 890 CYS B 891 SITE 1 AC3 3 TRP B 765 HIS B 770 GLN B 815 SITE 1 AC4 5 PRO A 737 GLY A 738 ARG A 740 ASN A 741 SITE 2 AC4 5 HOH A2106 CRYST1 58.164 63.897 70.051 90.00 95.57 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017193 0.000000 0.001677 0.00000 SCALE2 0.000000 0.015650 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014343 0.00000